Feedback / Questions
Keytruda (pembrolizumab) - Merck (MSD)
IPN60340 - Ipsen
http://clinicaltrials.gov/ct2/show/NCT04243499
Jan 28, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next